Atrial Fibrillation/Flutter Flashcards
Definition
Characterised by rapid, chaotic and ineffective atrial electrical conduction.
Often subdivided into:
o Permanent
o Persistent
o Paroxysmal
Aetiology/risk factors (systemic)
· There may be no identifiable cause
· Secondary causes lead to an abnormal atrial electrical pathway that results in AF
· Systemic Causes o Thyrotoxicosis o Hypertension o Pneumonia o Alcohol
Aetiology/risk factors (heart)
· Heart Causes
o Mitral valve disease o Ischaemic heart disease o Rheumatic heart disease o Cardiomyopathy o Pericarditis o Sick sinus syndrome o Atrial myxoma
Aetiology/risk factors (lung)
· Lung Causes
o Bronchial carcinoma
o PE
Epidemiology
· VERY COMMON in the elderly
· Present in 5% of those > 65 years
· May be paroxysmal
Presenting symptoms
· Often ASYMPTOMATIC
· Palpitations
· Syncope (if low output)
· Symptoms of the cause of AF
Signs on physical examination
· Irregularly irregular pulse
· Difference in apical beat and radial pulse
· Check for signs of thyroid disease and valvular disease
Investigations (bloods)
o Cardiac enzymes o TFT o Lipid profile o U&Es, Mg2+ and Ca2+ · Because there is increased risk of digoxin toxicity with hypokalaemia, hypomagnesaemia and hypercalcaemia
Investigations (other)
· ECG
o Uneven baseline with absent p waves
o Irregular intervals between QRS complexes
o Atrial flutter = saw-tooth
· Echocardiogram o May show: · Mitral valve disease · Left atrial dilatation · Left ventricular dysfunction · Structural abnormalities
Management plan (rhythm control)
First and foremost, try to treat any reversible causes (e.g. thyrotoxicosis, chest infection)
There are TWO main components to AF management:
· RHYTHM CONTROL
o If > 48 hrs since onset of AF
· Anticoagulate for 3-4 weeks before attempting cardioversion
o If < 48 hrs since onset of AF
· DC cardioversion (2 x 100 J, 1 x 200 J)
· Chemical cardioversion: flecainide or amiodarone
§ NOTE: flecainide is contraindicated if there is a history of ischaemic heart disease
o Prophylaxis against AF · Sotalol · Amiodarone · Flecainide · Consider pill-in-the-pocket (single dose of a cardioverting drug (e.g. flecainide) for patients with paroxysmal AF) strategy for suitable patients
Management plan (rate control)
o Chronic (Permanent) AF
· Control ventricular rate with:
§ Digoxin
§ Verapamil
§ Beta-blockers
· Aim for ventricular rate ~ 90 bpm
Management plan (stroke risk stratification)
o LOW RISK patients can be managed with aspirin
o HIGH RISK patients require anticoagulation with warfarin
o This is based on the CHADS-Vasc Score
o Risk factors include: · Previous thromboembolic event · Age > 75 yrs · Hypertension · Diabetes · Vascular disease · Valvular disease · Heart failure · Impaired left ventricular function
Possible complications
· THROMBOEMBOLISM
o Embolic stroke risk of 4% per year
o Risk is increased with left atrial enlargement or left ventricular dysfunction
· Worsening of existing heart failure
Prognosis
Chronic AF in a disease heart does not usually return to sinus rhythm